⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL28050031 | 0.97 | — | — | |
| Acetic Acid SCHEMBL28820430 | 0.92 | FFAR3 (0.37) | — | |
| SCHEMBL625520 | 0.77 | — | — | |
| SCHEMBL7567590 | 0.75 | MEN1 (0.46) | — | |
| SCHEMBL2337669 | 0.75 | — | — | |
| SCHEMBL18370 | 0.75 | — | — | |
| SCHEMBL15793249 | 0.75 | — | — | |
| SCHEMBL2694782 | 0.73 | — | — | |
| SCHEMBL355066 | 0.73 | — | — | |
| Hydrochloric Acid SCHEMBL6948114 | 0.73 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11766412-B2 | Methods of treating or alleviating adenylosuccinatelyase (ADSL) deficiency using spermidine or a pharmaceutically acceptable salt of spermidine | GENEHEAL BIOTECHNOLOGY CO., LTD. (CN) | 2023-09-26 | — | — | US | disclosed |
| US-20190209499-A1 | COMPOUNDS WEAKENING SAICAR SYNTHETASE ACTIVITY AND APPLICATIONS | GENEHEAL BIOTECHNOLOGY CO., LTD. (CN) | 2019-07-11 | — | — | US | disclosed |
| CN-103524373-B | Polyamines aryl buserelin chemical families, and cosmetics or cosmetics for skin application | 爱西美有限公司 | 2016-12-28 | — | — | CN | disclosed |
| WO-2014016613-A2 | THE USE OF TYPE-B LANTIBIOTIC-BASED COMPOUNDS HAVING ANTIMICROBIAL ACTIVITY | NOVACTA BIOSYSTEMS LIMITED (GB/GB) (GB) | 2014-01-30 | — | — | WO | disclosed |
| EP-2603204-A2 | FORMULATIONS FOR INFUSION OF TYPE B LANTIBIOTICS | Novacta Biosystems Limited (GB) | 2013-06-19 | — | — | EP | disclosed |
| WO-2012020219-A2 | FORMULATIONS FOR INFUSION OF TYPE B LANTIBIOTICS | NOVACTA BIOSYSTEMS LIMITED (GB) | 2012-02-16 | — | — | WO | disclosed |
| US-4841060-A | USING MIXED OXIDE CATALYST CONTAINING GROUP 1A AND/OR 2A, AND SILICON DIOXIDE | NIPPON SHOKUBAI KAGAKU KOGYO CO., LTD. (JP) | 1989-06-20 | — | — | US | disclosed |